Showing results (1271-1280 of 3,153) with videos related to
Sort By:
Pageof 316
Neuro-Oncology|December 25, 2014
Cytogenetic landscape of paired neurospheres and traditional monolayer cultures in pediatric malignant brain tumorsXiumei Zhao, Yi-Jue Zhao, Qi Lin, et al.Neuro-Oncology|December 21, 2014
Imaging of gliomas at 1.5 and 3 Tesla - A comparative studyLambros Tselikas, Raphaëlle Souillard-Scemama, Olivier Naggara, et al.Neuro-Oncology|November 26, 2014
Late morbidity in long-term survivors of childhood brain tumors: a nationwide registry-based study in FinlandMirja Erika Gunn, Tuire Lähdesmäki, Nea Malila, et al.Neuro-Oncology|February 26, 2016
Magnetic resonance analysis of malignant transformation in recurrent gliomaLlewellyn E Jalbert, Evan Neill, Joanna J Phillips, et al.Neuro-Oncology|February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastomaAlba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.Neuro-Oncology|December 15, 2015
MiR-138 exerts anti-glioma efficacy by targeting immune checkpointsJun Wei, Edjah K Nduom, Ling-Yuan Kong, et al.Neuro-Oncology|August 29, 2014
Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastomaKatharina Seystahl, Isabel Tritschler, Emese Szabo, et al.Neuro-Oncology|August 29, 2014
Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working GroupBrian M Alexander, Evanthia Galanis, W K Alfred Yung, et al.Neuro-Oncology|September 1, 2014
Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemnessWenzhong Du, Xing Liu, Lingchao Chen, et al.Neuro-Oncology|December 21, 2013
A deletion causing NF2 exon 9 skipping is associated with familial autosomal dominant intramedullary ependymomaIlyess Zemmoura, Patrick Vourc'h, Agathe Paubel, et al.Pageof 316